We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$121B
AUM Growth
+$9.79B
Cap. Flow
-$942M
Cap. Flow %
-0.78%
Top 10 Hldgs %
9.24%
Holding
5,958
New
1,032
Increased
1,969
Reduced
1,595
Closed
616

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$986M
2
SE icon
Sea Limited
SE
+$480M
3
SNOW icon
Snowflake
SNOW
+$441M
4
C icon
Citigroup
C
+$422M
5
ORCL icon
Oracle
ORCL
+$393M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$575M
2
AAPL icon
Apple
AAPL
+$515M
3
MA icon
Mastercard
MA
+$506M
4
DIS icon
Walt Disney
DIS
+$447M
5
BABA icon
Alibaba
BABA
+$434M

Sector Composition

Rank Sector Weight
1 Technology 13.97%
2 Consumer Discretionary 9.19%
3 Financials 7.48%
4 Healthcare 7.05%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROSS.WS
4626
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$245K ﹤0.01%
268,888
AWF
4627
AllianceBernstein Global High Income Fund
AWF
$875M
$243K ﹤0.01%
20,000
COHU icon
4628
Cohu
COHU
$2.41B
$243K ﹤0.01%
+6,374
New +$219K
CVCO icon
4629
Cavco Industries
CVCO
$4.46B
$243K ﹤0.01%
+764
New +$213K
MCRB icon
4630
Seres Therapeutics
MCRB
$51.4M
$243K ﹤0.01%
1,457
+648
+80% +$103K
PANA
4631
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$243K ﹤0.01%
25,008
+9,812
+65% +$95.9K
AIP icon
4632
Arteris
AIP
$1.13B
$242K ﹤0.01%
+11,448
New +$260K
ALB icon
4633
Albemarle
ALB
$15.8B
$242K ﹤0.01%
1,036
-400
-28% -$99K
BFS
4634
Saul Centers
BFS
$844M
$241K ﹤0.01%
4,550
-1,793
-28% -$89.2K
SONY icon
4635
Sony
SONY
$140B
$241K ﹤0.01%
9,535
-100,270
-91% -$2.39M
STOK icon
4636
Stoke Therapeutics
STOK
$2.16B
$241K ﹤0.01%
+10,065
New +$240K
TRC icon
4637
Tejon Ranch
TRC
$439M
$241K ﹤0.01%
+12,622
New +$239K
PDSB icon
4638
PDS Biotechnology
PDSB
$12.3M
$240K ﹤0.01%
+29,605
New +$319K
DISCK
4639
CALL
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$240K ﹤0.01%
+10,500
New +$253K
ALLY icon
4640
CALL
Ally Financial
ALLY
$13B
$238K ﹤0.01%
5,000
-128,400
-96% -$6.36M
DH icon
4641
Definitive Healthcare
DH
$77.2M
$238K ﹤0.01%
+8,697
New +$304K
IPSC icon
4642
Century Therapeutics
IPSC
$389M
$238K ﹤0.01%
15,037
-5,819
-28% -$109K
VIA
4643
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$237K ﹤0.01%
4,144
+1,782
+75% +$100K
SUNL
4644
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$237K ﹤0.01%
+2,478
New +$239K
DINO icon
4645
CALL
HF Sinclair
DINO
$16.9B
$236K ﹤0.01%
+7,200
New +$243K
KBAL
4646
DELISTED
Kimball International
KBAL
$236K ﹤0.01%
23,024
-9,883
-30% -$107K
CYCN icon
4647
Cyclerion Therapeutics
CYCN
$18.7M
$235K ﹤0.01%
6,830
-6,798
-50% -$321K
XAGE
4648
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
$235K ﹤0.01%
+811
New +$236K
PFC
4649
DELISTED
Premier Financial Corp. Common Stock
PFC
$234K ﹤0.01%
+7,566
New +$238K
MITT
4650
TPG Mortgage Investment Trust
MITT
$213M
$233K ﹤0.01%
22,685
-20,572
-48% -$233K

Similar funds

David Shaw's Q4 2021 Portfolio in Review

As of Q4 2021, David Shaw held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw's Q4 2021 filing shows 1,032 new, 1,969 increased, 1,595 reduced and 616 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B. The largest sale was Microsoft, an estimated $575M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

  • David Shaw's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
  • David Shaw added most to Sea Limited in Q4 2021, an estimated $480M increase.
  • David Shaw's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
  • David Shaw fully exited Aon in Q4 2021, selling an estimated $179M.
  • David Shaw's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
  • David Shaw opened 1,032 new positions and closed 616 in Q4 2021.
  • David Shaw's portfolio value rose 8.8% quarter-over-quarter to $121B.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.